Skip to content
Sorbitol
Sorbitol is a small molecule pharmaceutical. Sorbitol was first approved as Sorbitol-mannitol in plastic container on 1982-01-01. It is used to treat constipation and poisoning in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
chemically-induced disordersD064419
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Mannitol
+
Sorbitol
Tradename
Company
Number
Date
Products
SORBITOL-MANNITOL IN PLASTIC CONTAINERICU MedicalN-018316 RX1982-01-01
1 products, RLD, RS
Show 1 discontinued
Sorbitol
Tradename
Company
Number
Date
Products
SORBITOL 3.3% IN PLASTIC CONTAINERB. Braun MedicalN-016741 RX1982-01-01
1 products
SORBITOL 3% IN PLASTIC CONTAINERBaxterN-017863 RX1982-01-01
1 products
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
anubis barcelonaOTC monograph final2023-02-17
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
constipationHP_0002019D003248K59.0
poisoningEFO_0008546D011041T65.91
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A06: Drugs for constipation
— A06A: Drugs for constipation
— A06AD: Osmotically acting laxatives
— A06AD18: Sorbitol
— A06AG: Enema for constipation
— A06AG07: Sorbitol
B: Blood and blood forming organ drugs
— B05: Blood substitutes and perfusion solutions
— B05C: Irrigating solutions, blood substitutes and perfusion
— B05CX: Other irrigating solutions in atc
— B05CX02: Sorbitol
V: Various drug classes in atc
— V04: Diagnostic agents
— V04C: Other diagnostic agents in atc
— V04CC: Diagnostic agents for bile duct patency testing
— V04CC01: Sorbitol
HCPCS
No data
Clinical
Clinical Trials
33 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C613174—428
Castration-resistant prostatic neoplasmsD064129131——5
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSORBITOL
INN—
Description
D-glucitol is the D-enantiomer of glucitol (also known as D-sorbitol). It has a role as a sweetening agent, a laxative, a metabolite, a cathartic, a human metabolite, a food humectant, a Saccharomyces cerevisiae metabolite, an Escherichia coli metabolite and a mouse metabolite. It is an enantiomer of a L-glucitol.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Identifiers
PDB—
CAS-ID50-70-4
RxCUI9945
ChEMBL IDCHEMBL1682
ChEBI ID17924
PubChem CID5780
DrugBankDB01638
UNII ID—
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 48,698 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
4,734 adverse events reported
View more details